However, the association between TP53 mutations with HRD scores, coupled with the lack of association between TP53 mutations and mutational signatures such as aging or APOBEC-related signatures, suggests to us that, generally speaking, TP53 mutations affect tumour mutational burden rather than the other way around. Here, TP53 is linked to neoplasm.